Flu season is coming for Europe. How bad could it be this year?
It’s difficult to predict just how severe the influenza season will be each year, but public health experts say it could be harsh in Europe due to lagging vaccination rates and early signals from far-flung countries such as Japan and Australia.
News
Policy & Recommendations
Toward a Council Recommendation on the value of immunisation against respiratory infections
The Steering Group on the Prevention of Respiratory Infections launched a new manifesto at the #EURespiDay event held at the European Parliament in Brussels
Incorporating COVID-19 Into the Broader Narrative on Respiratory Diseases. A Citizens' and Patients’ Perspective Towards the Development of An EU Respiratory Health Plan
As COVID-19 transitions from a pandemic to an endemic disease, its integration into the broader policy and healthcare framework for respiratory diseases becomes imperative.
News
Policy & Recommendations
Closing immunisation gaps: A comprehensive EU framework for respiratory infection prevention
This year, 15 October marks the evolution of #EUFluDay into #EURespiDay, a broader call for EU action on respiratory infection prevention.
Mucosal COVID-19 vaccines in clinical development
Mucosal vaccines are designed to elicit both a strong systemic and mucosal immune response gaining importance as the next generation of vaccines
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination
The evolution of SARS-CoV-2 has resulted in antigenically distinct variants that challenge vaccine-induced immunity.
Respiratory viral infections awaken metastatic breast cancer cells in lungs
Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCCs) is crucial for addressing metastatic progression.
Cardiac Events in Adults Hospitalized for Respiratory Syncytial Virus vs COVID-19 or Influenza
What is the risk of acute cardiovascular complications in adults hospitalized for respiratory syncytial virus (RSV) vs influenza or SARS-CoV-2 Omicron infection?
